☰

Kathryn A. Tworkoski, Ph.D. - Publications

Affiliations: 
2013 Experimental Pathology Yale University, New Haven, CT 
Area:
Molecular Biology, Pathology, Oncology
Tree Info Similar researchers PubMed Report error

4 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Tworkoski K, Raab-Traub N. LMP1 Promotes Expression of Insulin-Like Growth Factor 1 (IGF1) To Selectively Activate IGF1 Receptor and Drive Cell Proliferation Journal of Virology. 89: 2590-2602. PMID 25520502 DOI: 10.1128/Jvi.02921-14  0.477
2013 Tworkoski KA, Platt JT, Bacchiocchi A, Bosenberg M, Boggon TJ, Stern DF. MERTK controls melanoma cell migration and survival and differentially regulates cell behavior relative to AXL. Pigment Cell & Melanoma Research. 26: 527-41. PMID 23617806 DOI: 10.1111/Pcmr.12110  0.453
2011 Tworkoski K, Singhal G, Szpakowski S, Zito CI, Bacchiocchi A, Muthusamy V, Bosenberg M, Krauthammer M, Halaban R, Stern DF. Phosphoproteomic screen identifies potential therapeutic targets in melanoma. Molecular Cancer Research : McR. 9: 801-12. PMID 21521745 DOI: 10.1158/1541-7786.Mcr-10-0512  0.451
2011 Godshalk SE, Paranjape T, Nallur S, Speed W, Chan E, Molinaro AM, Bacchiocchi A, Hoyt K, Tworkoski K, Stern DF, Sznol M, Ariyan S, Lazova R, Halaban R, Kidd KK, et al. A Variant in a MicroRNA complementary site in the 3' UTR of the KIT oncogene increases risk of acral melanoma. Oncogene. 30: 1542-50. PMID 21119596 DOI: 10.1038/Onc.2010.536  0.402
Show low-probability matches.